BCR and acute myeloid leukemia: After false discovery rate adjustment of the p-values, a significant over-expression of ABL1 in the BCR::ABL1-positive AML as compared to the other AML samples (log2 Fold Change = +1.80, adjusted p-value = 0.039) is observed (Table S4).